©The Author(s) 2020.
World J Hepatol. Dec 27, 2020; 12(12): 1136-1147
Published online Dec 27, 2020. doi: 10.4254/wjh.v12.i12.1136
Published online Dec 27, 2020. doi: 10.4254/wjh.v12.i12.1136
Table 3 Class B carbapenemase asset found in each pathogen
| Pathogens | Class B carbapenemase | |||||||||
| IMP-1 | IMP-1-like | IMP-4 | IMP-8 | VIM-1 | VIM-1-like | VIM-2 | VIM-2-like | VIM-4 | VIM-5 | |
| K. pneumoniae | + | + | + | + | + | + | + | |||
| S. marcescens | + | + | + | + | ||||||
| E. coli | + | + | + | |||||||
| E. cloacae | + | + | + | + | + | + | + | + | ||
| C. freundii | + | + | + | |||||||
- Citation: Fiore M, Di Franco S, Alfieri A, Passavanti MB, Pace MC, Petrou S, Martora F, Leone S. Spontaneous bacterial peritonitis due to carbapenemase-producing Enterobacteriaceae: Etiology and antibiotic treatment. World J Hepatol 2020; 12(12): 1136-1147
- URL: https://www.wjgnet.com/1948-5182/full/v12/i12/1136.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i12.1136